As the world’s first genuine intelligence linguistic AI solution, RWS’ Evolve allows pharmaceutical companies to harness the latest innovations in Generative AI in a fully secure, end-to-end Linguistic AI solution in a cost-efficient manner.
The solution automating post-editing to minimise manual work and optimise expert resources in translation workflows, increasing productivity while maximising returns on investment. With unique, self-improving AI scaled for enterprise-wide synergy, Evolve expedites and maximises the strategic value of translation services.
Why Evolve with RWS?
Evolve delivers the following benefits:
- Superior translations at scale — Our solution will deliver improved translation quality.
- Faster time to market — Our solution significantly speeds up localised content production to enable you to achieve faster time to market. ‘Linguistic AI’ reduces the human labour requirements in the workflow and automates more of the end-to-end translation process.
- Significant cost efficiencies — Evolve will drive cost efficiencies of 15-30% on your localisation spend.
- Secure, strategic AI adoption — Evolve empowers you to harness the potential of AI for your organisation. Secure and strategic, our enterprise-grade solution allows teams to access the benefits of AI without the risk of using unsecure tools such as ChatGPT or public online translation tools.
- Supporting exponential growth — Evolve is self-improving AI, meaning the more it’s used, the better it gets.
For more information about RWS Evolve, please download the free brochure by filling in the form above.